Novartis Ag (NVS) Total Current Liabilities (2009 - 2026)

Novartis Ag has disclosed Total Current Liabilities across 18 years of filings, most recently posting $31.7 billion for Q2 2026.

• In Q2 2026, Total Current Liabilities changed 0.11% year-over-year to $31.7 billion; the TTM figure through Jun 2026 stood at $31.7 billion (changed 0.11% YoY), while the FY2025 annual figure was $27.3 billion, down 4.93% from the prior year.
• Total Current Liabilities came in at $31.7 billion for Q2 2026 at Novartis Ag, up from $31.4 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $48.4 billion in Q3 2023 to a low of $26.4 billion in Q4 2023.
• Average Total Current Liabilities over 5 years is $30.6 billion, with a median of $29.5 billion recorded in 2022.
• Year-over-year, Total Current Liabilities surged 71.85% in 2023 and slumped 41.87% in 2024.
• Over 5 years, Total Current Liabilities stood at $28.7 billion in 2022, then slipped by 7.91% to $26.4 billion in 2023, then climbed by 8.72% to $28.7 billion in 2024, then declined by 4.93% to $27.3 billion in 2025, then climbed by 16.39% to $31.7 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $31.7 billion in Q2 2026, $31.4 billion in Q1 2026, and $27.3 billion in Q4 2025.